Skip to main content
. 2023 Apr 19;13:1130101. doi: 10.3389/fcimb.2023.1130101

Table 1.

CONRAD A18-146 demographics.

Group 1 (Sampling 4 and 48 hours post dosing)
(N=8)
Group 2 (Sampling 24 and 72 hours post dosing)
(N=8)
Total
(N=16)
Age in years Mean ±SD 39.0 ±4.72 40.5 ±7.39 39.8 ±6.04
Ethnicity (N, % of Group)
Hispanic or Latino 1 (12.5%) 2 (25.0%) 3 (18.8%)
Not Hispanic or Latino 7 (87.5%) 6 (75.0%) 13 (81.3%)
Race (N, % of Group)
American Indian or Alaska Native 1 (12.5%) 0 (0.0%) 1 (6.3%)
Asian 1 (12.5%) 0 (0.0%) 1 (6.3%)
Black or African American 2 (25.0%) 4 (50.0%) 6 (37.5%)
White 5 (62.5%) 4 (50.0%) 9 (56.3%)
Contraceptive Method Used On-Study (N, % of Group)
Hormonal Methods, Except Vaginal Rings and DMPA 2 (25.0%) 2 (25.0%) 4 (25.0%)
Sterilization of Participant 2 (25.0%) 3 (37.5%) 5 (31.3%)
Abstinence 3 (37.5%) 1 (12.5%) 4 (25.0%)
Consistent Use of Condoms 1 (12.5%) 2 (25.0%) 3 (18.8%)
Sexual Partner Status (N, % of Group)
Living with Partner 5 (62.5%) 4 (50.0%) 9 (56.3%)
Not Living with Partner 1 (12.5%) 3 (37.5%) 4 (25.0%)
No Partner 2 (25.0%) 1 (12.5%) 3 (18.8%)
Participant Ever Pregnant (N, % of Group)
Yes 8 (100.0%) 7 (87.5%) 15 (93.8%)
No 0 (0.0%) 1 (12.5%) 1 (6.3%)
Time Since Pregnancy (years)
Mean ±SD 9.0 ± 4.86 12.6 ± 7.11 10.6 ± 6.08